VPI-211

N/A

Report date: 2025/01/26 17:27:19

Base Information

Drug NameVPI-211
Drug Alias NameHIV-VaultVPI-211
ClassificationVaccines > Application > Therapeutic vaccineBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsAcquired Immunodeficiency SyndromeHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of California, Los Angeles
China Registration ClassN/A

Develop Information

Active CompaniesVault Pharma Inc
Inactive CompaniesN/A
Active IndicationsAcquired Immunodeficiency SyndromeHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A